{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:54:49Z","timestamp":1792979689256,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["825762"],"award-info":[{"award-number":["825762"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.taap.2025.117335","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:14:58Z","timestamp":1744269298000},"page":"117335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Activation of steroid hormone receptors by metabolism-disrupting chemicals"],"prefix":"10.1016","volume":"499","author":[{"given":"Sini","family":"Pitk\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna","family":"Niskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Mysore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einari A.","family":"Niskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma J.","family":"Palvimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Pijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinie","family":"van Beuningen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Rashidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thales","family":"Kronenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Poso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Liisa","family":"Levonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"K\u00fcblbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paavo","family":"Honkakoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.taap.2025.117335_bb0005","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/tx300463b","article-title":"Robust array-based coregulator binding assay predicting ER\u03b1-agonist potency and generating binding profiles reflecting ligand structure","volume":"26","author":"Aarts","year":"2013","journal-title":"Chem. Res. Toxicol."},{"issue":"295","key":"10.1016\/j.taap.2025.117335_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.toxlet.2018.06.1071","article-title":"Bisphenol A and octylphenol exacerbate type 1 diabetes mellitus by disrupting calcium homeostasis in mouse pancreas","volume":"1","author":"Ahn","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2025.117335_bb0015","doi-asserted-by":"crossref","first-page":"101602","DOI":"10.1016\/j.molmet.2022.101602","article-title":"Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice","volume":"66","author":"Attema","year":"2022","journal-title":"Mol. Metab."},{"issue":"2","key":"10.1016\/j.taap.2025.117335_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-17-0151","article-title":"Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis development","volume":"177","author":"Birzniece","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","article-title":"Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition","volume":"110","author":"Bledsoe","year":"2002","journal-title":"Cell"},{"issue":"51","key":"10.1016\/j.taap.2025.117335_bb0030","doi-asserted-by":"crossref","first-page":"49761","DOI":"10.1074\/jbc.M205641200","article-title":"Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP","volume":"277","author":"Borgius","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.taap.2025.117335_bb0035","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2016-1615","article-title":"Hepatic glucocorticoid receptor plays a greater role than adipose GR in metabolic syndrome despite renal compensation","volume":"157","author":"Bose","year":"2016","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.taap.2025.117335_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1096-7192(02)00043-4","article-title":"Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors","volume":"76","author":"Bramlett","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0045","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1210\/en.2018-00149","article-title":"Profiling of 3696 nuclear receptor-Coregulator interactions: A resource for biological and clinical discovery","volume":"159","author":"Broekema","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2025.117335_bb0050","doi-asserted-by":"crossref","first-page":"155269","DOI":"10.1016\/j.metabol.2022.155269","article-title":"Androgen receptor functions in pericentral hepatocytes to decrease gluconeogenesis and avoid hyperglycemia and obesity in male mice","volume":"135","author":"Chen","year":"2022","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.taap.2025.117335_bb0055","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/s41591-023-02553-8","article-title":"Interaction between estrogen receptor-\u03b1 and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women","volume":"29","author":"Cherubini","year":"2023","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.taap.2025.117335_bb0060","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab."},{"issue":"5906","key":"10.1016\/j.taap.2025.117335_bb0065","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1164847","article-title":"Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke\u2019s disease","volume":"322","author":"Chopra","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0070","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s41467-018-04176-x","article-title":"Defining a conformational ensemble that directs activation of PPAR\u03b3","volume":"9","author":"Chrisman","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.taap.2025.117335_bb0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.siny.2019.05.005","article-title":"The science of steroids","volume":"24","author":"Cole","year":"2019","journal-title":"Semin. Fetal Neonatal Med."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/aps.2014.133","article-title":"A structural perspective on nuclear receptors as targets of environmental compounds","volume":"36","author":"Delfosse","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinformat."},{"key":"10.1016\/j.taap.2025.117335_bb0095","doi-asserted-by":"crossref","first-page":"113266","DOI":"10.1016\/j.fct.2022.113266","article-title":"The alternative analog plasticizer BPS displays similar phenotypic and metabolomic responses to BPA in HepG2 and INS-1E cells","volume":"167","author":"Ferreira Azevedo","year":"2022","journal-title":"Food Chem. Toxicol."},{"issue":"398","key":"10.1016\/j.taap.2025.117335_bb0100","doi-asserted-by":"crossref","first-page":"115009","DOI":"10.1016\/j.taap.2020.115009","article-title":"Metabolomic-based assessment reveals dysregulation of lipid profiles in human liver cells exposed to environmental obesogens","volume":"1","author":"Franco","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2025.117335_bb0105","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.taap.2025.117335_bb0110","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2025.117335_bb0115","doi-asserted-by":"crossref","first-page":"105554","DOI":"10.1016\/j.tiv.2023.105554","article-title":"Interlaboratory prevalidation of a new in vitro transcriptional activation assay for the screening of (anti-)androgenic activity of chemicals using the UALH-hAR cell line","volume":"88","author":"Garoche","year":"2023","journal-title":"Toxicol. in Vitro"},{"issue":"5","key":"10.1016\/j.taap.2025.117335_bb0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nmeth.2411","article-title":"Single-molecule imaging of transcription factor binding to DNA in live mammalian cells","volume":"10","author":"Gebhardt","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.taap.2025.117335_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semcancer.2020.08.015","article-title":"Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators","volume":"73","author":"G\u00f3mez-Coronado","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0130","first-page":"62","article-title":"Reporter cell lines for the characterization of the interactions between human nuclear receptors and endocrine disruptors","volume":"11","author":"Grimaldi","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"2","key":"10.1016\/j.taap.2025.117335_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2018-00158","article-title":"Reproductive endocrinology of nonalcoholic fatty liver disease","volume":"40","author":"Grossmann","year":"2019","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0140","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"GTEx Consortium","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.taap.2012.06.003","article-title":"The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice","volume":"263","author":"Hao","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0150","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/acs.chemrestox.9b00058","article-title":"Organophosphorus flame retardants impair intracellular lipid metabolic function in human hepatocellular cells","volume":"32","author":"Hao","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"15","key":"10.1016\/j.taap.2025.117335_bb0155","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1074\/jbc.273.15.9270","article-title":"Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing","volume":"273","author":"Harnish","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.taap.2025.117335_bb0160","doi-asserted-by":"crossref","first-page":"13047","DOI":"10.3390\/ijerph182413047","article-title":"Metabolic syndrome and endocrine disrupting chemicals: An overview of exposure and health effects","volume":"18","author":"Haverinen","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.taap.2025.117335_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.taap.2025.117335_bb0170","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.taap.2025.117335_bb0175","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1124\/dmd.107.016568","article-title":"Human CYP2A6 is induced by estrogen via estrogen receptor","volume":"35","author":"Higashi","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"765","key":"10.1016\/j.taap.2025.117335_bb0180","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejphar.2015.08.052","article-title":"Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile","volume":"15","author":"Hikichi","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2003.08.037","article-title":"Effects of triaryl phosphates on mouse and human nuclear receptors","volume":"67","author":"Honkakoski","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"2 Pt A","key":"10.1016\/j.taap.2025.117335_bb0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijheh.2016.11.007","article-title":"Cumulative effects of antiandrogenic chemical mixtures and their relevance to human health risk assessment","volume":"220","author":"Howdeshell","year":"2017","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/j.taap.2025.117335_bb0195","series-title":"Assay Guidance Manual [Internet]","article-title":"HTS Assay Validation. 2012 May 1 [updated 2012 Oct 1]","author":"Iversen","year":"2004"},{"issue":"9","key":"10.1016\/j.taap.2025.117335_bb0200","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/js.2019-00201","article-title":"Urinary bisphenols and obesity prevalence among U.S. children and adolescents","volume":"3","author":"Jacobson","year":"2019","journal-title":"J. Endocr. Soc."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1074\/jbc.274.1.345","article-title":"The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta","volume":"274","author":"Johansson","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.taap.2025.117335_bb0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1289\/ehp.0901392","article-title":"In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project","volume":"118","author":"Judson","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2025.117335_bb0215","doi-asserted-by":"crossref","first-page":"101779","DOI":"10.1016\/j.molmet.2023.101779","article-title":"Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice","volume":"76","author":"Karpale","year":"2023","journal-title":"Mol. Metab."},{"issue":"14","key":"10.1016\/j.taap.2025.117335_bb0220","doi-asserted-by":"crossref","first-page":"1250218","DOI":"10.3389\/fendo.2023.1250218","article-title":"AIB1\/SRC-3\/NCOA3 function in estrogen receptor alpha positive breast cancer","volume":"30","author":"Kiliti","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"38","key":"10.1016\/j.taap.2025.117335_bb0225","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M109.025452","article-title":"Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism","volume":"284","author":"Koliwad","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.taap.2025.117335_bb0230","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2605.2009.01047.x","article-title":"Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment","volume":"33","author":"Kortenkamp","year":"2010","journal-title":"Int. J. Androl."},{"issue":"12","key":"10.1016\/j.taap.2025.117335_bb0235","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/mend.14.12.0569","article-title":"ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation","volume":"14","author":"Kotaja","year":"2000","journal-title":"Mol. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.taap.2025.117335_bb0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(03)01481-X","article-title":"Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43","volume":"466","author":"Krusekopf","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.taap.2025.117335_bb0245","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3390\/ijms21083021","article-title":"The EDCMET project: metabolic effects of endocrine disruptors","volume":"21","author":"K\u00fcblbeck","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41574-019-0273-8","article-title":"Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification","volume":"16","author":"La Merrill","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"38","key":"10.1016\/j.taap.2025.117335_bb0255","doi-asserted-by":"crossref","first-page":"36418","DOI":"10.1074\/jbc.M303913200","article-title":"Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner","volume":"278","author":"Lai","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.taap.2025.117335_bb0260","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.300.11.1303","article-title":"Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults","volume":"300","author":"Lang","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0265","first-page":"C1542","article-title":"Octylphenol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways","volume":"294","author":"Lee","year":"2008","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"10","key":"10.1016\/j.taap.2025.117335_bb0270","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.taap.2025.117335_bb0275","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1124\/dmd.113.055178","article-title":"17\u03b2-estradiol induces sulfotransferase 2A1 expression through estrogen receptor \u03b1","volume":"42","author":"Li","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0280","doi-asserted-by":"crossref","DOI":"10.1289\/EHP2505","article-title":"Differential in vitro biological action, Coregulator interactions, and molecular dynamic analysis of bisphenol A (BPA), BPAF, and BPS ligand-ER\u03b1 complexes","volume":"126","author":"Li","year":"2018","journal-title":"Environ. Health Perspect."},{"issue":"10","key":"10.1016\/j.taap.2025.117335_bb0285","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrendo.2012.100","article-title":"Nuclear receptor coregulators: modulators of pathology and therapeutic targets","volume":"8","author":"Lonard","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"47","key":"10.1016\/j.taap.2025.117335_bb0290","doi-asserted-by":"crossref","first-page":"17868","DOI":"10.1073\/pnas.0608711103","article-title":"Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program","volume":"103","author":"Louet","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.taap.2025.117335_bb0295","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"7","key":"10.1016\/j.taap.2025.117335_bb0300","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0305","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.taap.2025.117335_bb0310","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.24685","article-title":"Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver","volume":"55","author":"Marmugi","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.taap.2025.117335_bb0315","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0707601","article-title":"Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells","volume":"153","author":"Martin","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0320","first-page":"1372","article-title":"Processing of gene expression data generated by quantitative real-time RT-PCR","volume":"32","author":"Muller","year":"2002","journal-title":"Biotechniques"},{"issue":"9","key":"10.1016\/j.taap.2025.117335_bb0325","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrendo.2017.51","article-title":"Endocrine-disrupting chemicals and the regulation of energy balance","volume":"13","author":"Nadal","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.taap.2025.117335_bb0330","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/me.2012-1270","article-title":"The endocrine disrupting chemical tolylfluanid alters adipocyte metabolism via glucocorticoid receptor activation","volume":"27","author":"Neel","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.taap.2025.117335_bb0335","first-page":"42","article-title":"The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases","author":"Orchard","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0340","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pro.3978","article-title":"The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions","volume":"30","author":"Oughtred","year":"2021","journal-title":"Protein Sci."},{"issue":"8","key":"10.1016\/j.taap.2025.117335_bb0345","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1038\/ncomms15896","article-title":"Single-molecule analysis of steroid hormone receptor and cofactor action in living cells","volume":"21","author":"Paakinaho","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2025.117335_bb0350","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"10.1016\/j.taap.2025.117335_bb0355","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0092-8674(02)01169-8","article-title":"SRC-1 and TIF2 control energy balance between white and brown adipose tissues","volume":"111","author":"Picard","year":"2002","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.taap.2025.117335_bb0360","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1093\/emboj\/18.17.4608","article-title":"Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist","volume":"18","author":"Pike","year":"1999","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0365","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41598-017-01937-4","article-title":"Hepatic estrogen receptor \u03b1 is critical for regulation of gluconeogenesis and lipid metabolism in males","volume":"7","author":"Qiu","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.taap.2025.117335_bb0370","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fendo.2017.00304","article-title":"Cofactors as metabolic sensors driving cell adaptation in physiology and disease","volume":"3","author":"Rabhi","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.taap.2025.117335_bb0375","doi-asserted-by":"crossref","first-page":"104768","DOI":"10.1016\/j.envint.2019.04.040","article-title":"Phthalate exposure and metabolic effects: a systematic review of the human epidemiological evidence","volume":"132","author":"Radke","year":"2019","journal-title":"Environ. Int."},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0380","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1021\/acs.jmedchem.8b01105","article-title":"Nuclear receptors database including negative data (NR-DBIND): A database dedicated to nuclear receptors binding data including negative data and pharmacological profile","volume":"62","author":"R\u00e9au","year":"2019","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.taap.2025.117335_bb0385","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/oby.2009.419","article-title":"Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation","volume":"18","author":"Sargis","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.taap.2025.117335_bb0390","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2021.09.039","article-title":"Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease","volume":"76","author":"Sen","year":"2022","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.taap.2025.117335_bb0395","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.metabol.2012.12.007","article-title":"Testosterone deficiency induces markedly decreased serum triglycerides, increased small dense LDL, and hepatic steatosis mediated by dysregulation of lipid assembly and secretion in mice fed a high-fat diet","volume":"62","author":"Senmaru","year":"2013","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.taap.2025.117335_bb0400","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3803\/EnM.2021.1235","article-title":"Associations of phthalate metabolites and bisphenol A levels with obesity in children: the Korean National Environmental Health Survey (KoNEHS) 2015 to 2017","volume":"37","author":"Seo","year":"2022","journal-title":"Endocrinol. Metab. (Seoul)."},{"issue":"3","key":"10.1016\/j.taap.2025.117335_bb0410","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016709","article-title":"Signaling by nuclear receptors","volume":"5","author":"Sever","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0415","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.sxmr.2018.09.006","article-title":"Selective androgen receptor modulators: current knowledge and clinical applications","volume":"7","author":"Solomon","year":"2019","journal-title":"Sex Med. Rev."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0420","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/03602532.2022.2039688","article-title":"Through a glass, darkly? HepaRG and HepG2 cells as models of human phase I drug metabolism","volume":"54","author":"Stanley","year":"2022","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.taap.2025.117335_bb0425","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2\u20133","key":"10.1016\/j.taap.2025.117335_bb0435","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2011.08.001","article-title":"Characterization of steroid hormone receptor activities in 100 hydroxylated polychlorinated biphenyls, including congeners identified in humans","volume":"289","author":"Takeuchi","year":"2011","journal-title":"Toxicology"},{"issue":"502","key":"10.1016\/j.taap.2025.117335_bb0440","doi-asserted-by":"crossref","first-page":"110665","DOI":"10.1016\/j.mce.2019.110665","article-title":"Nuclear receptors are the major targets of endocrine disrupting chemicals","volume":"15","author":"Toporova","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0445","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1186\/1471-2164-15-1108","article-title":"RNA-Seq gene expression profiling of HepG2 cells: the influence of experimental factors and comparison with liver tissue","volume":"15","author":"Tyakht","year":"2014","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0450","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.reprotox.2010.04.007","article-title":"Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds","volume":"30","author":"van der Burg","year":"2010","journal-title":"Reprod. Toxicol."},{"issue":"9","key":"10.1016\/j.taap.2025.117335_bb0455","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jnutbio.2013.01.009","article-title":"Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6\/J mice","volume":"24","author":"Wahlang","year":"2013","journal-title":"J. Nutr. Biochem."},{"issue":"387","key":"10.1016\/j.taap.2025.117335_bb0460","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2017.06.007","article-title":"Anti-androgenic mechanisms of bisphenol A involve androgen receptor signaling pathway","volume":"15","author":"Wang","year":"2017","journal-title":"Toxicology"},{"issue":"24","key":"10.1016\/j.taap.2025.117335_bb0465","doi-asserted-by":"crossref","first-page":"21862","DOI":"10.1074\/jbc.M200764200","article-title":"Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha","volume":"277","author":"W\u00e4rnmark","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2025.117335_bb0470","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0475","first-page":"61","article-title":"The CompTox chemistry dashboard: a community data resource for environmental chemistry","volume":"9","author":"Williams","year":"2017","journal-title":"J. Chemother."},{"issue":"1","key":"10.1016\/j.taap.2025.117335_bb0480","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-019-09521-z","article-title":"Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention","volume":"21","author":"Yilmaz","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.taap.2025.117335_bb0485","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.taap.2025.117335_bb0490","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbadis.2010.10.006","article-title":"Role of nuclear receptor SHP in metabolism and cancer","volume":"1812","author":"Zhang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"Pt A","key":"10.1016\/j.taap.2025.117335_bb0495","doi-asserted-by":"crossref","first-page":"105133","DOI":"10.1016\/j.envint.2019.105133","article-title":"Glucocorticoid and mineralocorticoid receptors and corticosteroid homeostasis are potential targets for endocrine-disrupting chemicals","volume":"133","author":"Zhang","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.taap.2025.117335_bb0500","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molmet.2017.12.012","article-title":"Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding","volume":"8","author":"Zhu","year":"2018","journal-title":"Mol. Metab."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:23:11Z","timestamp":1746609791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":98,"alternative-id":["S0041008X25001115"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117335","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of steroid hormone receptors by metabolism-disrupting chemicals","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117335"}}